News

Articles

Catalent will invest $350 million into integrated biologics drug substance and drug product manufacturing at Bloomington, Indiana facility.

Catalent to Invest $350 Million in Manufacturing Facility in Bloomington, Indiana

Moderna, Pfizer, and BioNTech are seeking FDA approval for a fourth dose of their respective COVID-19 vaccines.

COVID-19 Vaccine Manufacturers Submit Appeals to FDA for Fourth Dose

Novartis will pay Voyager up to $1.75 billion for access to Voyager’s novel Tracer AAV capsids for potential use with three CNS targets.

Voyager Therapeutics Announces License Agreement with Novartis Worth Up to $1.75 Billion

Hovione has announced that Jean-Luc Herbeaux will take over for Guy Villax as CEO on April 1, 2022.

Hovione Appoints Jean-Luc Herbeaux as New CEO

 Washington Editor, jillwechsler7@gmail.com.

Califf will face challenges that include COVID-19, opioids, and user fees.

A Rocky Road Ahead for Commissioner Califf 

Medicago and GSK have announced that Health Canada has approved COVIFENZ, an adjuvanted plant-based COVID-19 vaccine.

Medicago and GSK Announce the Approval by Health Canada of COVIFENZ, an Adjuvanted Plant-Based COVID-19 Vaccine

Novavax announces the first doses of Nuvaxovid COVID-19 vaccine have begun shipping to European Union member states.

Novavax Begins Shipping its COVID-19 Vaccine to European Union Member States

The turnkey facilities will promote scalable vaccine production for an end-to-end manufacturing network for mRNA-based vaccines in Africa.

BioNTech Plans to Build Modular mRNA Manufacturing Facilities in Africa

ImmunoGen and Eli Lilly and Company have entered into an agreement that gives Lilly exclusive rights to research, develop, and commercialize ADCs designed for targets selected by Lilly from ImmunoGen’s camptothecin technology.

ImmunoGen Grants Lilly Exclusive Research, Development, and Commercialization License in $1.7+ Billion ADC Deal

Eli Lilly and Company is investing $1 billion to establish a new manufacturing stie in Concord, N.C., to manufacture parenteral products and devices.

Top News